One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Plaquenil & hrt Chloroquine treatment for vivax malaria Do you have to wean off hydroxychloroquine Macular Society Eye screening for patients taking hydroxychloroquine Hydroxychloroquine is a medication used to treat several conditions including rheumatoid arthritis, systemic lupus erythematosus, some skin conditions especially photosensitive ones and others that involve inflammation. It was previously used in the treatment and Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently prescribed immunosuppressant for the syndrome. However, evidence regarding its efficacy is limited. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Hydroxychloroquine eye exam guidance ncbi Chloroquine And Hydroxychloroquine Toxicity - nih.gov, Hydroxychloroquine for Sjögren Syndrome Symptoms - JAMA Proguanil plus chloroquineChloroquine treats which plasmodiumsDoes plaquenil help with inflammationPlaquenil maculopathy fundus autofluorescenceWhat does plaquenil trat Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Marmor MF1, Kellner U, Lai TY, Lyons JS, Mieler WF; American Academy of Ophthalmology. Author information 1Eye Institute at Stanford, Stanford University, Palo Alto, California, USA. Revised recommendations on screening for chloroquine and.. Hydroxychloroquine Plaquenil -. Hydroxychloroquine Plaquenil Toxicity and Recommendations for Screening. On examination, best-corrected visual acuity was 20/50 in each eye. Slit-lamp examination was significant for mild to moderate cataract in each eye. Dilated fundus examination was notable for only mild bilateral macular pigment alterations Figures 1-2. Humphrey visual field 10-2 evaluation revealed dense bilateral central scotomas Figures 3-4. On examination, a telltale sign of hydroxychloroquine toxicity is a bilateral change in the retinal pigment epithelium of the macula that gives the commonly described appearance of a bull’s-eye. This is a late finding, however, and too late for screening to be useful. Hydroxychloroquine HCQ is an anti-malarial medication that has in recent times been utilized as treatment for a variety of autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus, and other inflammatory and dermatologic conditions. Retinal toxicity from HCQ, and its analog, chloroquine, has been recognized for many years.2,3 By some estimates, in the United.